{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:29:04Z","timestamp":1788568144547,"version":"build-2803163510"},"reference-count":31,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Germline pathogenic variants (PVs) of succinate dehydrogenase subunit D (\n                      <jats:italic>SDHD<\/jats:italic>\n                      ) are major genetic causes of pheochromocytomas and paragangliomas. Existing studies have reported inconsistent findings and lack a comprehensive synthesis regarding penetrance, multifocality and metastatic risk in carriers of\n                      <jats:italic>SDHD<\/jats:italic>\n                      PVs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically assess age-specific penetrance (in all carriers) and the proportions of multifocality, metastatic disease and mortality among affected carriers, and explore potential genotype\u2013phenotype associations through a systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Eligible observational studies were selected from PubMed, MEDLINE and EMBASE that reported age-specific penetrance (in all carriers) and the proportions of multifocality, metastatic disease and mortality among affected carriers (those with tumours). Additionally, data on specific\n                      <jats:italic>SDHD<\/jats:italic>\n                      variants associated with tumour multifocality or metastatic behaviour were collected. Following independent data extraction and quality assessment by two reviewers, these proportions were meta-analysed using random-effects models or fixed-effect model to generate pooled estimates with 95% CIs and prediction intervals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Age-specific penetrance increased from 20% at 20 years of age (95%\u2009CI 16% to 25%)\u2009to 58% at 40 years (95%\u2009CI 48% to 67%)\u2009and 82% at 60 years (95%\u2009CI 75% to 90%). Among the affected\n                      <jats:italic>SDHD<\/jats:italic>\n                      PV carriers, the pooled proportions were 75% (95% CI 72% to 79%) for multifocal tumours, 3% (95% CI 2% to 4%) for metastatic disease and 1% (95% CI 1% to 2%) for mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SDHD<\/jats:italic>\n                      PV carriers exhibit increasing age-specific penetrance, with a high proportion of patients having multifocal tumours but low proportions of metastatic disease and mortality, providing partial evidence for the need for lifelong monitoring of\n                      <jats:italic>SDHD<\/jats:italic>\n                      PV carriers. However, evidence linking specific variants to these phenotypes is limited and requires further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420251060752.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmg-2025-111235","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:20:35Z","timestamp":1776273635000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and prognosis of\n                    <i>SDHD<\/i>\n                    pathogenic variant carriers: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1714-1475","authenticated-orcid":false,"given":"Xinquan","family":"Lian","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-0241","authenticated-orcid":false,"given":"Liping","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"},{"name":"Department of Clinical Laboratory, Enze Hospital,Taizhou Enze Medical Center(Group), Luqiao, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0890-141X","authenticated-orcid":false,"given":"Jiayin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3063-2954","authenticated-orcid":false,"given":"Mengqi","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"},{"name":"Department of Clinical Laboratory, Enze Hospital,Taizhou Enze Medical Center(Group), Luqiao, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2969-9209","authenticated-orcid":false,"given":"Yunmeng","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Hsin","family":"Tung","sequence":"additional","affiliation":[{"name":"Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-3558","authenticated-orcid":false,"given":"Bo","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China"},{"name":"Department of Clinical Laboratory, Enze Hospital,Taizhou Enze Medical Center(Group), Luqiao, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026072308352376000_63.8.467.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651"},{"key":"2026072308352376000_63.8.467.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00492-3"},{"key":"2026072308352376000_63.8.467.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04378-6"},{"key":"2026072308352376000_63.8.467.4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S2213-8587(23)00038-4","article-title":"Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","volume":"11","author":"Ta\u00efeb","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072308352376000_63.8.467.5","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2009.112"},{"key":"2026072308352376000_63.8.467.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.8.943"},{"key":"2026072308352376000_63.8.467.7","doi-asserted-by":"crossref","unstructured":"Rijken JA , van Hulsteijn LT , Dekkers OM , et al . n.d. Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers. Cancers (Basel) 11:103. doi:10.3390\/cancers11010103","DOI":"10.3390\/cancers11010103"},{"key":"2026072308352376000_63.8.467.8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2756"},{"key":"2026072308352376000_63.8.467.9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/ejhg.2015.36","article-title":"No evidence for increased mortality in SDHD variant carriers compared with the general population","volume":"23","author":"van Hulsteijn","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"2026072308352376000_63.8.467.10","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106324"},{"key":"2026072308352376000_63.8.467.11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hed.25604","article-title":"Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A 18 F-FDOPA PET\/CT study","volume":"41","author":"Amodru","year":"2019","journal-title":"Head Neck"},{"key":"2026072308352376000_63.8.467.12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/cen.12223","article-title":"No difference in phenotype of the main Dutch SDHD founder mutations","volume":"79","author":"Dulk","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026072308352376000_63.8.467.13","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1210\/clinem\/dgae233","article-title":"Outcomes of SDHB Pathogenic Variant Carriers","volume":"109","author":"Davidoff","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072308352376000_63.8.467.14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072308352376000_63.8.467.15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ando.2024.05.024","article-title":"Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field","volume":"85","author":"Cardot-Bauters","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"2026072308352376000_63.8.467.16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081523","article-title":"Head and Neck Paragangliomas: Overview of Institutional Experience","volume":"16","author":"Vimawala","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026072308352376000_63.8.467.17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/imj.14250","article-title":"Higher risk of phaeochromocytoma\/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study","volume":"49","author":"Hong","year":"2019","journal-title":"Intern Med J"},{"key":"2026072308352376000_63.8.467.18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164014","article-title":"Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and\/or Paraganglioma","volume":"13","author":"Yonamine","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026072308352376000_63.8.467.19","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2017-105127"},{"key":"2026072308352376000_63.8.467.20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.12659\/PJR.897490","article-title":"Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes","volume":"81","author":"Micha\u0142owska","year":"2016","journal-title":"Pol J Radiol"},{"key":"2026072308352376000_63.8.467.21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-2942-5"},{"key":"2026072308352376000_63.8.467.22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1306308"},{"key":"2026072308352376000_63.8.467.23","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21790"},{"key":"2026072308352376000_63.8.467.24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0032-1311610","article-title":"Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update","volume":"44","author":"Persu","year":"2012","journal-title":"Horm Metab Res"},{"key":"2026072308352376000_63.8.467.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04097.x"},{"key":"2026072308352376000_63.8.467.26","first-page":"275","article-title":"Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management","volume":"32","author":"Hermsen","year":"2010","journal-title":"Cell Oncol"},{"key":"2026072308352376000_63.8.467.27","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21136"},{"key":"2026072308352376000_63.8.467.28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2504"},{"key":"2026072308352376000_63.8.467.29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1862"},{"key":"2026072308352376000_63.8.467.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.16.2057"},{"key":"2026072308352376000_63.8.467.31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2975"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2025-111235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:35:34Z","timestamp":1784820934000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2025-111235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/jmg-2025-111235"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2025-111235","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}